Consolidated Statements of Cash Flows
For the years ended December 31 ($Cdn thousands) |
Note | 2015 | 2014 |
---|---|---|---|
See accompanying notes to consolidated financial statements. | |||
Operating activities | |||
Net earnings | $63,362 | $183,413 | |
Adjustments for: | |||
Depreciation and amortization | 312,518 | 338,983 | |
Deferred charges | 5,834 | 61,869 | |
Unrealized losses on derivatives | 92,166 | 40,569 | |
Share-based compensation | 25 | 16,853 | 15,808 |
Loss on sale of assets | 2,326 | 44,762 | |
Finance costs | 20 | 103,615 | 111,853 |
Finance income | (5,417) | (7,402) | |
Share of loss from equity-accounted investees | 758 | 17,141 | |
Impairment charge | 9,12 | 215,488 | 326,693 |
Other income | 21 | (54,409) | (35,353) |
Discontinued operation | 6 | — | (127,243) |
Income tax recovery | 22 | (142,630) | (175,268) |
Interest received | 3,922 | 5,935 | |
Income taxes paid | (92,758) | (233,716) | |
Other operating items | 24 | (71,618) | (87,862) |
Net cash provided by operations | 450,010 | 480,182 | |
Investing activities | |||
Additions to property, plant and equipment | (358,562) | (480,108) | |
Increase in long-term receivables, investments and other | 17,557 | 11,569 | |
Proceeds from sale of property, plant and equipment | 198 | 701 | |
Net cash used in investing (continuing operations) | (340,807) | (467,838) | |
Net cash provided by investing (discontinued operation) | 6 | — | 447,096 |
Net cash used in investing | (340,807) | (20,742) | |
Financing activities | |||
Increase in debt | — | 496,476 | |
Decrease in debt | (10) | (351,046) | |
Interest paid | (69,507) | (78,144) | |
Proceeds from issuance of shares, stock option plan | — | 6,228 | |
Contributions from non-controlling interest | — | 794 | |
Dividends paid | (158,313) | (158,200) | |
Net cash used in financing | (227,830) | (83,892) | |
Increase (decrease) in cash and cash equivalents, during the year | (118,627) | 375,548 | |
Exchange rate changes on foreign currency cash balances | 10,648 | 3,126 | |
Cash and cash equivalents, beginning of year | 566,583 | 187,909 | |
Cash and cash equivalents, end of year | $458,604 | $566,583 | |
Cash and cash equivalents is comprised of: | |||
Cash | $240,603 | $86,664 | |
Cash equivalents | 218,001 | 479,919 | |
Cash and cash equivalents | $458,604 | $566,583 |